Search results
Cucumber recall: Destroy and throw away these cucumbers distributed to 14 states
NJ.com· 49 minutes agoFresh Start Produce Sales Inc. is recalling whole cucumbers shipped to 14 states, including New...
The FDA is reviewing the use of MDMA to treat PTSD today
Quartz· 2 hours agoThe Food and Drug Administration is getting closer to making a decision on whether to approve the...
The FDA should stop letting drug companies skip steps - The Boston Globe
The Boston Globe· 7 hours agoThe FDA approves some new medical treatments quickly, before confirmatory trials are carried out, to...
FDA reviews MDMA for PTSD treatment; Biden to issue executive order on border policy
NPR· 2 hours agoA panel of FDA experts starts reviewing clinical trial data today to decide whether to approve the...
FDA fast tracks Quince Therapeutics’ rare ataxia drug EryDex
Pharmaceutical Technology via Yahoo Finance· 3 hours agoCalifornia-based biotech Quince Therapeutics has won fast track designation from the US Food and...
FDA panel to review psychedelic drug MDMA for first time
Reuters· 3 hours agoThe meeting by the agency's independent experts is the farthest that a drug based on MDMA, commonly...
Food Industry Gets Warning Shot Over Flour Suspected in Outbreak
Bloomberg Law· 5 hours agoAn FDA finding that tara flour is unsafe is a rare example of the agency taking assertive action against a food ingredient, and potentially exposes the involved manufacturers ...
FDA approves first liquid, nonstimulant ADHD treatment
Medical Xpress· 3 hours agoThe U.S. Food and Drug Administration has approved Tris Pharma's once-daily Onyda XR (clonidine...
Recall alert: Baraka ground black pepper recalled over potential salmonella contamination
WSB-TV 2 Atlanta· 28 minutes agoThe Food and Drug Administration has announced the recall of ground black pepper.
FDA selects Larimar Therapeutics for new program inspired by Operation Warp Speed - The Business...
The Business Journals· 3 hours agoNomlabofusp, an experimental therapy for Friedreich’s ataxia being developed by Larimar Therapeutics, was chosen for the FDA's Support for Clinical Trials Advancing Rare Disease ...